Navigation Links
Diabetes Management Provider ActiveCare Announces Cost Savings Of Over $4,000 Per Year Per Diabetic Member
Date:11/15/2012

SALT LAKE CITY, Nov. 15, 2012 /PRNewswire/ -- ActiveCare, Inc. (OTC.BB: ACAR), the service leader in disease and diabetes management solutions, announced a dramatic decrease in diabetic claims in the first twelve months of its relationship with Caprock HealthPlans. ActiveCare's revolutionary health monitoring and information technology combined with a dedicated staff of care specialists has lead to a healthier Caprock. By collecting real-time biometric readings ActiveCare is able to interpret the readings and communicate with the plan members, caregivers, physicians, diabetes management and wellness coordinators within minutes of a blood glucose test. "ActiveCare has made an immediate impact on the programs we are able to offer our plan members. Monitoring and care services have enabled us to better meet the needs of our members and lower the cost of care," stated David M. Adams, president of Caprock. "This savings is a great platform for us to continue to grow our relationship with ActiveCare by allowing us to expand this service to all of our current customers."

As a result of the rapid adoption of its revolutionary Diabetes Management System during the past six months ActiveCare has grown from 661 to more than 6,000 program members. "Many organizations aspire to 'deliver better care at a lower cost.' We actually do it," notes Michael Jones, Chief Operating Officer of ActiveCare. "By combining real-time monitoring of blood glucose levels with analysis of individuals' previous care, we are able to guide plan members as they proactively treat their disease. The result is better care and a reduction of diabetes-related claims by $4,000 per year." The Company is projecting to add an additional 8,000 new members by the end of the year.

About ActiveCare
ActiveCare, Inc. is the telehealth and personal emergency response solution leader. Headquartered in Salt Lake City, Utah, and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare is committed to providing consistent excellence in quality and safety, and friendly care for members and caregivers alike. To learn more about ActiveCare, Inc., visit the website at www.activecare.com or contact investor/media relations at 877-862-5545 or ir@activecare.com.

About Caprock HealthPlans, Inc.
Caprock HealthPlans, Inc. is a Lubbock, Texas, based Third Party Administrator formed in June of 2000 and operates with a Certificate of Authority issued by the Texas Department of Insurance. We provide turnkey health plan administration services to businesses and governmental entities electing to self-insure their employer sponsored healthcare benefit plan.

Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE ActiveCare, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
2. Risk of developing diabetes higher in neighborhoods that arent walk-friendly: Study
3. Cystic fibrosis disrupts pancreas two ways in CF-related diabetes
4. Shedding new light on one of diabetes most dangerous complications
5. A mechanism providing clues for research into pancreatic diabetes is described
6. Specific toxic byproduct of heat-processed food may lead to increased body weight and diabetes
7. Drink made from berry wine may provide tasty drug for diabetes
8. Organic study of live pancreatic tissue yields new opportunities for diabetes research
9. 10 new diabetes gene links offer picture of biology underlying disease
10. Hormone in fruit flies sheds light on diabetes cure, weight-loss drug for humans
11. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: